- Stocks
- Pages
- Blogs
- Research Reports
sink_data

View

app landing page

View

bse

View

nse

View

Holiday

View

blog author

View

Author

View

Research Baskets

View

high stocks test page

View

MF_API

View

What is a Demat Account? Meaning, Benefits, Types & How It Works
4 September 2026
Read Blog

What is Mutual Fund: Definition, Benefits & How to Invest in it 
3 September 2026
Read Blog

What is an IPO? Full Form, Meaning & How It Works
2 September 2026
Read Blog

Portfolio Allocation Strategy During Interest Rate Cycles
30 June 2026
Read Blog

What happens after a company gets delisted?
19 June 2026
Read Blog

FII vs DII: Key Differences Explained
16 June 2026
Read Blog

What Is REIT?
15 June 2026
Read Blog

Difference Between Bull and Bear Market
12 June 2026
Read Blog

What is IOC in Share Market?
11 June 2026
Read Blog

What Is a Short Delivery in Share Market?
10 June 2026
Read Blog

View All Blogs

Technical Newsletter: 10-Sept-2026
10 September 2026
Read Report

Apeejay Surrendra Park Hotels (PARKHOTE IN) – Management Meet Update – Execution timelines remain a key monitorable – BUY
10 September 2026
Read Report

Technical Newsletter: 9-Sept-2026
09 September 2026
Read Report

HDFC Asset Management Company (HDFCAMC IN) – Analyst Meet Update – Structural play on formalization of the economy – BUY
09 September 2026
Read Report

The Beat – DCX Systems set for a booming upside!
02 January 2025
Read Report

Technical Newsletter: 8-Sept-2026
08 September 2026
Read Report

JSW Steel (JSTL IN) – Q3FY25 Result Update – Better quarter, but HRC situation yet to improve – HOLD
27 January 2025
Read Report

PCBL Chemical (PCBL IN) – Company Update – Import mix turns favourable – Upgrade to ‘BUY’
08 September 2026
Read Report

ICICI Bank (ICICIBC IN) – Q3FY25 Result Update – Asset quality remains best-in-class – BUY
27 January 2025
Read Report

Information Technology – Sector Report – BPO to intelligent solutions, the next growth chapter
08 September 2026
Read Report

View All Reports
Login
Open Account

Marksans Pharma Ltd

Q: What is the current share price of Marksans Pharma Ltd?

As of 17-Sep-2026, 09:42:31 the share price for Marksans Pharma Ltd. is ₹ 320.9 on the NSE (Note: Prices are dynamic and update frequently during market hours).

Small Cap | Pharmaceuticals

₹ 320.9 4.45(1.41%)

Last updated: 17-Sep-2026 , 09:42:31

Marksans Pharma Ltd Price Today Marksans Pharma Ltd share price is ₹320.9 as on 17-Sep-2026, Up 1.41% from the previous close of ₹316.45. The stock has traded between ₹322.3 and ₹312.95 today, against a 52-week range of ₹155 to ₹349.95. Over the past year the stock is Up 125.77% range. Market capitalisation stands at ₹15067.69 crore.

Performance

Low: ₹312.95 High: 322.3

Previous Close	₹ 316.45
High	₹ 322.3
Volume	2264075
52W Range	₹ 155 - ₹ 349.95

Open	₹ 315.95
Low	₹ 312.95
Market Cap	₹ 15067.69 Cr

Marksans Pharma Ltd Technicals

Current Price

₹ 320.9 4.45 (1.41%)

EMASMA

20 Day	₹ 320.742
50 Day	₹ 299.416
100 Day	₹ 270.903
200 Day	₹ 244.003

20 Day	₹ 326.185
50 Day	₹ 295.073
100 Day	₹ 263.297
200 Day	₹ 220.047

Marksans Pharma Ltd Fundamentals

ROCE	23.604
P/E Ratio	44.580
P/B Ratio	8.680
Industry P/E	8.680
Debt to Equity	50.183

ROE	18.199
EPS	7.100
Dividend Yield	0.280
Book Value	36.462
Face Value	1.000

Marksans Pharma Ltd Financials

Particulars	Y202603	Y202503	Y202403	Y202303	Y202203
Total Revenue	1445.009	1240.161	915.346	715.686	700.54
Total Expenses	1053.466	996.902	743.454	583.651	566.032
Profit After Tax	300.698	188.272	133.758	102.866	103.988

Marksans Pharma Ltd Shareholding Pattern

Promoter Holdings	43.874 %
FIIs	17.468 %
DIIs	1.826 %
MutualFund	4.364 %
Retail	28.052 %
Others -	4.415 %

About Marksans Pharma Ltd

Marksans Pharma Limited was formerly incorporated as 'Tasc Pharmaceuticals Limited' in April, 1982. Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited from 10th October, 2005. The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation. The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. In 2004-05, the Company amalgamated with M/s. Marksans Pharma Limited, pursuant to High Court order dated 19th August, 2005. The Company acquired majority stake in Nova Pharmaceuticals Australasia Private Limited in 2005; further, it acquired two companies, Bell Sons & Company (Druggists) Limited and Relonchem Limited in the UK in 2008. The Company received first ANDA approval in the USA in 2011. It acquired Time-Cap Laboratories Inc. in the US in 2015. The Company launched the CNS-Cerebella division in FY 2017-18. It launched soft gelatin capsules, a niche category, Launched two products and received CRL for 4 ANDAs for approval with the USFDA. The Company commissioned a new R&D center at Navi Mumbai, apart from one in Goa in 2019-20. Access Healthcare for Medical Products LLC, a Dubai-based front-marketing and promotion company was acquired in June, 2022. In 2023-24, Company acquired the business unit of Tevapharm India Private Limited in Verna, Goa as a going concern via slu ...

Similar Stocks

Ambalal Sarabhai Enterprises Ltd Pharmaceuticals	₹ 40.25 +0.43 (+1.08%)
Amrutanjan Health Care Ltd Pharmaceuticals	₹ 490.50 +0.1 (+0.02%)
Astrazeneca Pharma India Ltd Pharmaceuticals	₹ 6,716.50 +13.5 (+0.2%)
Bliss GVS Pharma Ltd Pharmaceuticals	₹ 697.00 +16.5 (+2.42%)
Abbott India Ltd Pharmaceuticals	₹ 26,025.00 -100 (-0.38%)
Cipla Ltd Pharmaceuticals	₹ 1,353.20 -4.8 (-0.35%)

FAQs on Marksans Pharma Ltd

1. Can I buy Marksans Pharma Ltd from PL Capital? ›

Yes, you can invest in Marksans Pharma Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Marksans Pharma Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Marksans Pharma Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Marksans Pharma Ltd pay dividends? ›

Yes, Marksans Pharma Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Marksans Pharma Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.

3. What is the current share price of Marksans Pharma Ltd ? ›

As of 17-Sep-2026 , 09:42:31 the share price for Marksans Pharma Ltd. is ₹ 320.9 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Marksans Pharma Ltd ? ›

The 52-week high and low of Marksans Pharma Ltd share price is ₹ 155 - ₹ 349.95 as of 17-Sep-2026 , 09:42:31 .

5. What is the market capitalisation of Marksans Pharma Ltd? ›

Market capitalisation of Marksans Pharma Ltd is ₹15067.69Cr as of 17-Sep-2026.

6. What is the current P/E ratio of Marksans Pharma Ltd? ›

The P/E (price-to-earnings) ratio of Marksans Pharma Ltd is 44.580.

7. What is the current P/B ratio of Marksans Pharma Ltd? ›

The P/B (price-to-book) ratio of Marksans Pharma Ltd is 8.680.

8. What is the shareholding pattern of Marksans Pharma Ltd? ›

As of 17-Sep-2026, promoters hold 43.874%, foreign institutional investors hold 17.468%, domestic institutional investors hold 1.826%, and the public holds 28.052%.